MAAN – Pioneers in
De-Addiction Treatment Formulations

MAAN Pharmaceuticals Ltd. is a home grown Global pharmaceutical company operating in more than markets. The company is focused on offering solutions to overcome the serious menace of substance abuse and improve the patient’s quality of life.

We identify and develop formulations that address unmet medical needs in de-addiction treatment. Our endeavour is to meet the pressing challenges by applying innovative technology to offer superior quality products at affordable prices.

We have a strong presence in Indian subcontinent which is complemented with expanding footprints in the Global markets. Our product portfolio includes internationally accepted formulation of Buprenorphine and Naltrexone in branded as well as generic forms .

MAAN- CORPORATE MILESTONES & ACHIEVEMENTS

2009

Research & Development:

Successfully completed pre-clinical trials for Drug X
2011

Clinical Trials

Initiated Phase I clinical trial for Drug X.
2015

Achievement

Achieved positive results in Phase I clinical trial for Drug X.
2018

Product Development

iled New Drug Application (NDA) with the FDA for Drug Z
2021

Completion

Filed New Drug Application (NDA) with the FDA for Drug Z
2024

Financial Goal

Achieved its targeted revenue which was set during the budget process

MAAN – Manufacturing Facilities

MAAN,s philosophy to use innovative technology is complemented by state of the art WHO –GMP manufacturing facility at Mehsana in Gujarat.

We have dedicated facilities to manufacture various dosage forms like tablets, hard and soft gelatin capsules, orally disintegrating films, sachets, syrups & suspensions, creams, ointments, injections including ampoules & vials.

MAAN’s manufacturing facilities are also approved by regulatory bodies of various countries .The facilities are equipped with advanced automation systems with automatic data recording monitors for process control like air distribution, temperature, humidity, auto cleaning process etc.

We are committed to produce products that consistently meets quality criteria at every single stage of the process

MAAN’s foray into New Therapy Segments

Cardiology

TINECTEPLASE
FCM
ENOXAPARIN

Nephrology  |  Urology

FCM
ENOXAPARIN
MEROPENEM

Oncology

FCM
ENOXAPARIN
MEROPENEM

MAAN – Global Presence

Copyright © 2011, Maan Pharmaceuticals Ltd. All rights reserved.